De Cecco et al. showed in a recent study that enforced expression of hsa-miR-302b, targeting HDAC4 gene in ovarian carcinoma cells, significantly enhanced cisplatin cytotoxicity [51]. This evidence concerns the gene HDAC4 and ovarian carcinoma.